Metastatic Lung Cancer : News

Healthline's Premium Tools

Symptom Search
Discover possible causes based on the symptoms you enter.

It's fast, convenient and easy to use.
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
... date and still able to do it." The 36-year-old mother of two sons, Patrick, 20, and Devin, 16, is living with metastatic cancer - cancer originating in her breast and lymph nodes that has spread to her liver, lung and brain. In March 2007, doctors ...
Source:Nashua Telegraph
Date:August 25, 2008
AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that it has ...
Source:Business Wire
Date:August 25, 2008
... OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product ...
Source:TMCnet
Date:August 25, 2008
... the meeting. For more information on these items and other research that was presented, go to www.asco.org/ . Breast Cancer The Particulars: Previous studies have shown that adding bevacizumab to taxane chemotherapy agents for patients with ...
Source:Physician's Weekly
Date:August 24, 2008
... Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer. OGX-011 is currently completing five Phase 2 clinical studies in prostate, lung and breast cancer, and is ...
Source:News-Medical.Net
Date:August 24, 2008
Main Category: Lung Cancer Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 23 Aug 2008 - 0:00 PDT printer friendly view / write opinions rate article Human ...
Source:Medical News Today
Date:August 23, 2008
... is treatment following surgery or local radiation, for patients with hepatocellular carcinoma (HCC), or primary liver cancer. "Nexavar is the only systemic therapy with proven efficacy and tolerability in HCC across multiple patient populations," ...
Source:Medical News Today
Date:August 22, 2008
... life. Mesothelium refers to the wrapping structure of most of the bodily organs in our body and mesothelioma is the cancer that occurs in mesothelium. Like any other cancerous conditions, abnormal cell growth is observed in the area of mesothelium ...
Source:Associated Content
Date:August 20, 2008
... correlation between galectin-9 (Gal-9) expression and metastasis in patients with malignant melanoma and breast cancer. This study verified the ability of Gal-9 to inhibit lung metastasis in experimental mouse models using highly metastatic B16F10 ...
Source:Glycobiology
Date:August 18, 2008
... MITI) "Up 25.00% in Friday" Micromet, Inc., a biopharmaceutical company, develops antibodies for the treatment of cancer, inflammation, and autoimmune diseases. Its products under preclinical development include MT103 that is developed using BiTE ...
Source:Emailwire.com
Date:August 18, 2008
London, UK, and Cambridge, MA, 15 August 2008 - Antisoma plc today announced survival data from its phase II study of ASA404 in hormone-refractory prostate cancer, in which patients were randomised to receive ...
Source:Market Wire
Date:August 14, 2008
Some people whose cancer had spread to different parts of the body had their tumours eradicated by precisely targeted radiation, say researchers who tested the therapy.
Source:CBC
Date:August 14, 2008
... remained and grew. The team at the University of Chicago Medical Center reported the findings in the journal Clinical Cancer Research. New tumors appeared but the treated tumors were stopped in eight of the patients. Weichselbaum said higher doses ...
Source:RedOrbit
Date:August 14, 2008
Advertisement
Back to Top